Huron Capital Completes Acquisition of Lab Crafters

Based in Ronkonkoma, New York, Lab Crafters has a strong reputation as a premium brand in a highly specialized market, building close relationships with its loyal, highly respected customer base.

“Lab Crafters offers competitive, differentiated products to its customers,” said Brian Walker, Partner of Strategic Leadership at Huron Capital. “The company has already gained meaningful share in the laboratory furniture market, and its loyal customers include some of the nation’s largest Fortune 500 companies and premier research institutions. Huron has invested in Lab Crafters because we believe the company is capable of accelerated growth and we are focused on pursuing a number of strategic initiatives to diversify and expand this runway.”

Walker, a former CEO of Herman Miller, will serve as a member of Lab Crafters board of directors. Founder Robert DeLuca, Sr. will continue to lead the company as CEO, and Robert DeLuca, Jr. will continue to operate as President.

“We are proud to have built Lab Crafters into one of the leading manufacturers of specialized furniture for laboratories in the U.S.,” DeLuca, Sr. said. “We are confident that our partnership with Huron will provide the necessary capital and industry expertise to further accelerate our national growth while we continue to serve our existing customers.”

Robert DeLuca, Sr. and his management team have developed Lab Crafters into a company that is well respected by its customers, makes products that are increasingly sought after by the market, and is ultimately poised for growth,” said Huron Capital Partner Scott Hauncher. “We are excited about Lab Crafters future and pleased to welcome the company to our firm as its newest platform.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version